(S)‐Allyl Cysteine Derivatives as a New‐type Cholinesterase Inhibitor

Publisher： John Wiley & Sons Inc

E-ISSN： 1229-5949|36|1|52-58

ISSN： 1229-5949

Source： BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol.36, Iss.1, 2015-01, pp. : 52-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Methotrexate on the Expression of a Cysteine Protease Inhibitor (Type 2 Cystatin) in Rat Sebaceous Glands

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 12, 1996-12 ,pp. : 863-870

John Wiley & Sons Inc

Access to resources Recommend Favorite

Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

By Tahrani Abd   Piya Milan   Barnett Anthony  

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 736-736

Springer Publishing Company

Access to resources Recommend Favorite

The cognitive effects of cholinesterase inhibitor treatment in every-day practice

By Kapaki E.   Paraskevas G. P.  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 871-876

Informa Healthcare

Access to resources Recommend Favorite

Novel N‐(2,2′‐disubstituted‐2H‐cromenyl)‐N′,N″‐disubstituted Guanidine Derivatives as an S‐Nitrosoglutathion Reductase Inhibitor

By  

BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol. 36, Iss. 9, 2015-09 ,pp. : 2224-2229

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of Pneumonia in New Users of Cholinesterase Inhibitors for Dementia

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 5, 2015-05 ,pp. : 869-876

John Wiley & Sons Inc

Access to resources Recommend Favorite